Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.098 | 0.08 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.089 | 0.09 |